Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

The importance of clinical trials on dosing

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 29.01.20
Views: 88

Prof Peter Rothwell - University of Oxford, Oxford, UK

Prof Peter Rothwell speaks to ecancer at the International Aspirin Foundation Scientific Conference 2019 in Rome about the key findings from clinical trials about dosing.

Prof Rothwell explains that there is a lack of modern trials comparing different doses as well as the dosing regimen, but that this is beginning to change.

He also highlights some of the factors to consider when working out the right doses for individual patients. 

Read more on the highlights from the 2019 International Aspirin Foundation Scientific Conference here.


Related videos

follow us

SIOG metastatic renal cell carcinoma

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation